Sarilesin (trifluoroacetate salt) |
| Catalog No.GC90537 |
AT2 수용체 작용제 펩타이드
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Sarilesin is a peptide angiotensin II type 2 (AT2) receptor agonist.1 It binds to AT2 receptors (Ki = 0.14 nM) and induces neurite outgrowth in NG108-15 cells when used at a concentration at 100 nM, an effect that can be inhibited by the AT2 receptor antagonist PD 123310. Intrathecal administration of sarilesin (1 µg/µl) increases mean arterial pressure and heart rate in rats.2
Review for Sarilesin (trifluoroacetate salt)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Sarilesin (trifluoroacetate salt)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *